Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates

BACKGROUND: Omaveloxolone is a synthetic oleanane triterpenoid that pharmacologically activates Nrf2, a master transcription factor that regulates genes with antioxidative, anti-inflammatory, and mitochondrial bioenergetic properties, and is being evaluated in patients with Friedreich’s ataxia. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Reisman, Scott A, Gahir, Sarabjit S, Lee, Chun-Yue I, Proksch, Joel W, Sakamoto, Mitsumasa, Ward, Keith W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475100/
https://www.ncbi.nlm.nih.gov/pubmed/31118567
http://dx.doi.org/10.2147/DDDT.S193889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475100/
https://www.ncbi.nlm.nih.gov/pubmed/31118567
http://dx.doi.org/10.2147/DDDT.S193889

Ejemplares similares